Skip to content

Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment

Impact of Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05817630
Acronym
siliconeoil
Enrollment
32
Registered
2023-04-18
Start date
2023-02-15
Completion date
2023-04-05
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Detachment

Brief summary

Our study observes and analyses the influence of the duration of tamponade with silicone oil on the foveal and parafoveal thickness.

Detailed description

Retrospective Cohort study Retrospective review of records of eyes with Rhegmatogenous Retinal Detachment (RRD, for whom pars plana vitrectomy and silicone oil had been performed, in the period between January 2019 and December 2021. After checking inclusion and exclusion criteria; we will enroll all the cases. We shall observe the duration of silicone oil tamponade, and then divide the cases; accordingly; into 2 groups (Cohort). * Group A: 3 months SO Tamponade * Group B: 6 months SO Tamponade

Interventions

OTHERSilicone oil Tamponade for Retinal Detachment

eyes with Rhegmatogenous Retinal Detachment (RRD, for whom pars plana vitrectomy and silicone oil had been performed

Sponsors

Dar El Oyoun Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* • Silicone oil (SO) tamponade ( up to 6 months) * Attached retina under SO * Attached retina 3 months after Silicone oil Removal (SOR) * Normal fellow eye ( no retinal detachment or macular disease) * OCT scan performed for the operated eyes (before SOR, and 3 months after SOR), and for the fellow eye (at any time during the study)

Exclusion criteria

* • Rhegmatogenous Retinal Detachment (RRD) with other tamponades ( e.g.: Gas, Densiron) * SO tamponade less than 3 months, or more than 6 months * Recurrent RD under SO * Recurrent RD within 3 months after SOR * One eyed * Vitrectomized fellow eye * Retinal detachment, or macular disease in the fellow eye. * Posterior staphyloma * Anisometropia (history, refraction if possible, spectacles prescription) * Absence of any of the OCT scans performed for the operated eyes (before SOR, and 3 months after SOR), and for the fellow eye (at any time during the study)

Design outcomes

Primary

MeasureTime frameDescription
• Change in PFT after SORfrom baseline fellow eye to 1 month after silicone oil removal• Change in PFT after SOR (from baseline fellow eye) (microns, %) (each group)
Change in CFT just before SOR (central foveal thickness)baseline to time just before silicone oil removalChange in CFT just before SOR (from baseline fellow eye) (microns, %) (each group)
Change in PFT just before SOR (Parafoveal thickness)baseline to time just before silicone oil removalChange in PFT just before SOR (from baseline fellow eye) (microns, %) (each group)
• Change in CFT after SORfrom baseline fellow eye to 1 month after silicone oil removal• Change in CFT after SOR (from baseline fellow eye) (microns, %) (each group)

Secondary

MeasureTime frameDescription
• Relative Risk of severe CFT Thinning before SOR (between group A and B)baseline to time just before silicone oil removal• Relative Risk of severe CFT Thinning before SOR (between group A and B)
• Relative Risk of severe PFT Thinning before SOR (between group A and Bbaseline to time just before silicone oil removal• Relative Risk of severe PFT Thinning before SOR (between group A and B
• Relative Risk of severe CFT Thinning after SOR (between group A and B)from baseline fellow eye to 1 month after silicone oil removal• Relative Risk of severe CFT Thinning after SOR (between group A and B)
• Relative Risk of severe PFT Thinning after SOR (between group A and B)from baseline fellow eye to 1 month after silicone oil removal• Relative Risk of severe PFT Thinning after SOR (between group A and B)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026